Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine

Liyan Mei; Kaixin Gao; Xiaojuan He; Per-Johan Jakobsson; Runyue Huang

doi:10.3389/fphar.2023.1135803

Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine

Front Pharmacol. 2023 Feb 3:14:1135803. doi: 10.3389/fphar.2023.1135803. eCollection 2023.

Authors

Liyan Mei¹, Kaixin Gao¹, Xiaojuan He², Per-Johan Jakobsson³, Runyue Huang^{1

4

5

6}

Affiliations

¹ The Second Affiliated Hospital, Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
² China Academy of Chinese Medical Sciences, Beijing, China.
³ Karolinska Institutet (KI), Solna, Sweden.
⁴ Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
⁵ State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
⁶ Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.

No abstract available

Keywords: DMARDs-like effects; disease-modifying antirheumatic drugs (DMARDs); new strategies; rheumatic diseases; traditional Chinese medicine (TCM).

Publication types

Editorial